Please Wait

Applying Filters...

Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Tetrahydrozoline HCl

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

7 API Suppliers, 3 USDMF, 1 CEP/COS, 1 JDMF, 1 KDMF, 3 NDC API, 3 Listed Suppliers, $ API Reference Price

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

51 FDF Dossiers, 3 FDA Orange Book, 24 Europe, 10 Canada, 5 South Africa, 9 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 1 DKSH, 1 Nanjing Well Pharmaceutical, 7 Kirsch Pharma, 7 Actylis, 1 BASF, 2 Finar, 3 Gangwal Chemicals, 1 Kerry, 2 Microlex e.U, 1 Nanjing Bold Chemical, 2 Pluviaendo, 1 Roquette, 6 Seppic, 1 Symrise

EXCIPIENTS BY APPLICATIONS

18 Parenteral, 12 Solubilizers, 5 Topical, 3 Surfactant & Foaming Agents, 3 Emulsifying Agents, 3 Thickeners and Stabilizers, 2 Film Formers & Plasticizers, 2 Fillers, Diluents & Binders, 2 API Stability Enhancers, 1 Controlled & Modified Release, 1 Direct Compression, 1 Co-Processed Excipients, 1 Rheology Modifiers, 1 Chewable & Orodispersible Aids, 1 Taste Masking